Sequenom has promoted several members of its management team. William Welch is now the president and chief operating officer. He was previously senior vice president of diagnostics and has overseen the commercial operations of the MaterniT21 Plus test. Dirk van den Boom has been appointed executive vice president of research and development and chief technology officer from his position of senior vice president of research and development, which he has held since 2010. He joined the company in 1998. Ron Lindsay is now executive vice president of strategic planning. He was previously the executive vice president of research and development.
Fluidigm has named Frederic Walder to serve as its chief operating officer. Walder has been chief business officer at Fluidigm since 2010. From 1992 to 2010, Walder held various senior executive posts at Thermo Fisher Scientific.